According to our findings, PUDP is strongly and positively correlated with a range of tumor-promoting immune cells such as Tregs, MDSCs, and CAFs, suggesting that PUDP may influence the progression and prognosis of patients with HCC by interacting with immunosuppressive cells in the tumor microenvironment. This evidence concerns the gene PUDP and neoplasm.